NPPB and infarction: Although no other neuropeptide besides BNP and NT-proBNP is routinely used in practical evaluation, there is indirect evidence of their ability to predict morbidity and mortality in patients with infarction by decreasing it in patients treated with RAAS inhibitors [77,78] Some studies have also shown that a higher renin/aldosterone ratio is correlated with higher chances of developing ventricular remodeling [79].